Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy.


Journal

Breast cancer (Tokyo, Japan)
ISSN: 1880-4233
Titre abrégé: Breast Cancer
Pays: Japan
ID NLM: 100888201

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 03 04 2021
accepted: 31 10 2021
pubmed: 15 11 2021
medline: 3 3 2022
entrez: 14 11 2021
Statut: ppublish

Résumé

We re-evaluated acute and early-late toxicity-related factors among pre-pectoral immediate tissue expander/implant (TE/I) breast reconstruction (BR) unselected, first-era, cases, including previous breast radiation treatment and post-mastectomy radiation therapy (PMRT). A retrospective analysis of 146 (117 therapeutic and 29 prophylactic) pre-pectoral reconstructions, between 2012 and 2016, considered patient-related (age, body mass index [BMI], smoke-history, comorbidity, BRCA mutation), and treatment-related characteristics (previous irradiation, axillary surgery, PMRT, pre- and postoperative chemotherapy, endocrine therapy, and target-therapy). Safety was evaluated as acute and early-late complications, and TE/I failures. At multivariate analysis of the 146 cases (117 patients submitted to BR) a significant factor related to acute toxicity was: BMI ≥ 25 (31.3% [≥ 25] vs 8.8% [< 25]; OR 4.44, 95% CI 1.56-12.6; p = 0.003), while previous breast surgery on ipsilateral side presented a borderline significance (31.6% [previous surgery] vs 7.4% [no previous surgery]; OR 3.74, 95% CI 0.97-14.40; p = 0.055). Factors significantly related to TE/I failure were: current or previous smoking exposition (13.8% [smokers] vs 2.6% [non-smokers]; OR 7.32, 95% CI 1.37-39.08; p = 0.02) and preoperative chemotherapy (18.8% [yes] vs 3.5% [no]; OR 8.16, 95% CI 1.29-51.63; p = 0.026). At 4-year median follow-up, 3 deaths, 5 locoregional recurrences, and 14 distant metastases occurred. Immediate pre-pectoral BR is safe and effective, with low rates of acute and early-late complications. BMI and previous breast surgery were related to higher complications but not failure; smoking and preoperative chemotherapy were related to TE/I explant. Previous RT and PMRT were related neither to early-late toxicity nor failure.

Identifiants

pubmed: 34775540
doi: 10.1007/s12282-021-01314-0
pii: 10.1007/s12282-021-01314-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

302-313

Informations de copyright

© 2021. The Author(s), under exclusive licence to The Japanese Breast Cancer Society.

Références

American Society of Plastic Surgeons Statistics. http://www.plasticsurgery.org/Documents/news-resources/statistics . Accessed 4 Feb 2016.
Endara M, Chen D, Verma K, Nahabedian MY, Spear SL. Breast reconstruction following nipple-sparing mastectomy: a systematic review of the literature with pooled analysis. Plast Reconstr Surg. 2013;132(5):1043–54.
pubmed: 23924650
Snyderman RK, Guthrie RH. Reconstruction of the female breast following radical mastectomy. Plast Reconstr Surg. 1971;47:565e7.
Radovan C. Breast reconstruction after mastectomy using the temporary expander. Plast Reconstr Surg. 1982;69(2):195–208.
pubmed: 7054790
Lapin R, Elliott M, Juri H. The use of an integral tissue expander for primary breast reconstruction. Aesthet Plast Surg. 1985;9:221e6.
Gruber RP, Kahn RA, Lash H, Maser MR, Apfelberg DB, Laub DR. Breast reconstruction following mastectomy: a comparison of submuscular and subcutaneous techniques. Plast Reconstr Surg. 1981;67:312e7.
Argenta LC, Marks MW, Grabb WC. Selective use of serial expansion in breast reconstruction. Ann Plast Surg. 1983;11(3):188–95.
pubmed: 6638818
Nahabedian MY. Acellular dermal matrices in primary breast reconstruction: principles, concepts and indications. Plast Reconstr Surg. 2012;130:44–53.
Casella D, Bernini M, Bencini L, et al. TiLoop® Bra mesh used for immediate breast reconstruction: comparison of retropectoral and subcutaneous implant placement in a prospective single-institution series. Eur J Plast Surg. 2014;37(11):599–604.
pubmed: 25339795 pmcid: 4197328
Reitsamer R, Peintinger F. Prepectoral implant placement and complete coverage with porcine acellular dermal matrix: a new technique for direct-to-implant breast reconstruction after nipple-sparing mastectomy. J Plast Reconstr Aesthet Surg. 2015;68(2):162–7.
pubmed: 25455288
Woo A, Harless C, Jacobson SR. Revisiting an old place: single surgeon experience on post-mastectomy subcutaneous implant based breast reconstruction. Plast Reconstr Surg. 2015;136(4 Suppl):83.
Bernini M, Calabrese C, Cecconi L, et al. Subcutaneous direct-to-implant breast reconstruction: surgical, functional, and aesthetic results after long-term follow-up. Plast Reconstr Surg Glob Open. 2016;3(12):e574.
pubmed: 26893999 pmcid: 4727683
Casella D, Calabrese C, Bianchi S, et al. Subcutaneous tissue expander placement with synthetic titanium-coated mesh in breast reconstruction: long-term results. Plast Reconstr Surg Glob Open. 2016;3(12):e577.
pubmed: 26894002 pmcid: 4727686
Zhu L, Mohan AT, Abdelsattar JM, et al. Comparison of subcutaneous versus submuscular expander placement in the first stage of immediate breast reconstruction. J Plast Reconstr Aesthet Surg. 2016;69(4):e77-86.
pubmed: 26922050
Sigalove S, Maxwell GP, Sigalove NM, et al. Prepectoral implant-based breast reconstruction: rationale, indications, and preliminary results. Plast Reconstr Surg. 2017;139(2):287–94.
pubmed: 28121858
Bettinger LN, Waters LM, Reese SW, et al. Comparative study of prepectoral and subpectoral expander-based breast reconstruction and Clavien IIIb score outcomes. Plast Reconstr Surg Glob Open. 2017;5(7):e1433.
pubmed: 28831365 pmcid: 5548588
Nadeem R. Prepectoral implant-based breast reconstruction; complete acellular dermal matrix wrap or anterior circumferential cover. Breast J. 2018;24(2):223–4.
pubmed: 28763153
Vidya R. Prepectoral breast reconstruction or muscle-sparing technique with the Braxon porcine acellular dermal matrix. Plast Reconstr Surg Glob Open. 2017;5(6):e1364.
pubmed: 28740777 pmcid: 5505838
Sbitany H, Piper M, Lentz R. Prepectoral breast reconstruction: a safe alternative to submuscular prosthetic reconstruction following nipple-sparing mastectomy. Plast Reconstr Surg. 2017;140(3):432–43.
pubmed: 28574950
Vidya R, Masià J, Cawthorn S, et al. Evaluation of the effectiveness of the prepectoral breast reconstruction with Braxon dermal matrix: first multicenter European report on 100 cases. Breast J. 2017;23(6):670–6.
pubmed: 28481477
Jafferbhoy S, Chandarana M, Houlihan M, et al. Early multicentre experience of pre-pectoral implant based immediate breast reconstruction using Braxon®. Gland Surg. 2017;6(6):682–8.
pubmed: 29302486 pmcid: 5750316
Tasoulis MK, Iqbal FM, Cawthorn S, MacNeill F, Vidya R. Subcutaneous implant breast reconstruction: time to reconsider? Eur J Surg Oncol. 2017;43(9):1636–46.
pubmed: 28528191
Chatterjee A, Nahabedian MY, Gabriel A, et al. Early assessment of post-surgical outcomes with pre-pectoral breast reconstruction: a literature review and meta-analysis. J Surg Oncol. 2018;117(6):1119–30.
pubmed: 29346711
Wazir U, Mokbel K. The evolving role of pre-pectoral ADM-assisted implant-based immediate breast reconstruction following skin-sparing mastectomy. Am J Surg. 2018;216(3):639–40.
pubmed: 29397895
Mitchell MP, Wagner J, Butterworth J. Subcutaneous implant-based breast reconstruction, a modern challenge in postmastectomy radiation planning. Pract Radiat Oncol. 2018;8(3):153–6.
pubmed: 29233522
Harvey KL, Mills N, White P, Holcombe C, Potter S, Pre-BRA Feasibility Study Steering Group. The Pre-BRA (pre-pectoral Breast Reconstruction EvAluation) feasibility study: protocol for a mixed-methods IDEAL 2a/2b prospective cohort study to determine the safety and effectiveness of pre-pectoral implant-based breast reconstruction. BMJ Open. 2020;10(1):e03364. https://doi.org/10.1136/bmjopen-2019-033641 .
doi: 10.1136/bmjopen-2019-033641
Baker JL Jr. Owsley JQ Jr, Peterson RA, eds. Augmentation mammaplasty. In: Symposium on aesthetic surgery of the breast. 1978:St. Louis: Mosby;256–263.
Elswick SM, Harless CA, Bishop SN, et al. Prepectoral implant-based breast reconstruction with postmastectomy radiation therapy. Plast Reconstr Surg. 2018;142(1):1–12.
pubmed: 29878988
Vidya R, Iqbal FM. A guide to prepectoral breast reconstruction: a new dimension to implant-based breast reconstruction. Clin Breast Cancer. 2017;17(4):266–71.
pubmed: 28190760
Baker BG, Irri R, MacCallum V, Chattopadhyay R, Murphy J, Harvey JR. A prospective comparison of short-term outcomes of subpectoral and prepectoral strattice-based immediate breast reconstruction. Plast Reconstr Surg. 2018;141(5):1077–84.
pubmed: 29697602
Ho AL, Bovill ES, Macadam SA, Tyldesley S, Giang J, Lennox PA. Postmastectomy radiation therapy after immediate two-stage tissue expander/implant breast reconstruction: a University of British Columbia perspective. Plast Reconstr Surg. 2014;134(1):1e–10e.
pubmed: 25028850
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–16.
Whelan TJ, Olivotto IA, MA.20 Study Investigators, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373(4):307–16. https://doi.org/10.1056/NEJMoa1415340 .
doi: 10.1056/NEJMoa1415340 pubmed: 26200977 pmcid: 4556358
Poortmans PM, Collette S, EORTC Radiation Oncology and Breast Cancer Groups, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373(4):317–27. https://doi.org/10.1056/NEJMoa1415369 .
doi: 10.1056/NEJMoa1415369 pubmed: 26200978
Sinnott CJ, Persing SM, Pronovost M, Hodyl C, McConnell D, Ott YA. Impact of postmastectomy radiation therapy in prepectoral versus subpectoral implant-based breast reconstruction. Ann Surg Oncol. 2018;25(10):2899–908.
pubmed: 29978367
Ricci JA, Epstein S, Momoh AO, Lin SJ, Singhal D, Lee BT. A meta-analysis of implant-based breast reconstruction and timing of adjuvant radiation therapy. J Surg Res. 2017;218:108–16.
pubmed: 28985836
Cordeiro PG, Albornoz CR, McCormick B, Hudis CA, Hu Q, Heerdt A, Matros E. What is the optimum timing of postmastectomy radiotherapy in two-stage prosthetic reconstruction: radiation to the tissue expander or permanent implant? Plast Reconstr Surg. 2015;135(6):1509–17.
pubmed: 25742523 pmcid: 5004350
Koutcher L, Ballangrud A, Cordeiro PG, et al. Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction. Radiother Oncol. 2010;94(3):319–23.
pubmed: 20096946
Sbitany H. Important considerations for performing prepectoral breast reconstruction. Plast Reconstr Surg. 2017;140:7S-13S.
pubmed: 29166342
Ito H, Ueno T, Suga H, et al. Risk factors for skin flap necrosis in breast cancer patients treated with mastectomy followed by immediate breast reconstruction. World J Surg. 2018. https://doi.org/10.1007/s00268-018-4852-y .
doi: 10.1007/s00268-018-4852-y pubmed: 30051240 pmcid: 6329739
Riggio E, Toffoli E, Tartaglione C, Marano G, Biganzoli E. Local safety of immediate reconstruction during primary treatment of breast cancer. Direct-to-implant versus expander-based surgery. J Plast Reconstr Aesthet Surg. 2018; pii: S1748-6815(18)30368-1.
Lam TC, Borotkanics R, Hsieh F, Salinas J, Boyages J. Immediate two-stage prosthetic breast reconstruction failure: radiation is not the only culprit. Plast Reconstr Surg. 2018;141(6):1315–24.
pubmed: 29750759
McCarthy CM, Mehrara BJ, Riedel E, et al. Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg. 2008;121(6):1886–92.
pubmed: 18520873
Bezuhly M, Temple C, Sigurdson LJ, et al. Immediate postmastectomy reconstruction is associated with improved breast cancer-specific survival: evidence and new challenges from the Surveillance, Epidemiology, and End Results database. Cancer. 2009;115:4648–54.
pubmed: 19634163
Lee HH, Hou MF, Wei SY, et al. Comparison of long-term outcomes of postmastectomy radiotherapy between breast cancer patients with and without immediate flap reconstruction. PLoS ONE. 2016;11:e0148318.
pubmed: 26863006 pmcid: 4749188
McCarthy CM, Pusic AL, Sclafani L, et al. Breast cancer recurrence following prosthetic, postmastectomy reconstruction: incidence, detection, and treatment. Plast Reconstr Surg. 2008;121:381–8.
pubmed: 18300953
Aurilio G, Bagnardi V, Nole F, et al. Outcome of immediate breast reconstruction in patients with nonendocrine-responsive breast cancer: a monoinstitutional case-control study. Clin Breast Cancer. 2015;15:e237-241.
pubmed: 25908443
Eriksen C, Frisell J, Wickman M, et al. Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study. Breast Cancer Res Treat. 2011;127:439–46.
pubmed: 21409394
Zhang P, Li CZ, Wu CT, et al. Comparison of immediate breast reconstruction after mastectomy and mastectomy alone for breast cancer: A meta-analysis. Eur J Surg Oncol. 2017;43:285–93.
pubmed: 27503441

Auteurs

Marco Bernini (M)

Breast Surgery, Breast Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, University of Florence, L.go Brambilla 3, 50134, Florence, Italy. marco.bern@tin.it.

Icro Meattini (I)

Department of Biomedical, Experimental and Clinical Sciences "M. Serio", University of Florence, Florence, Italy.
Radiotherapy Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.

Calogero Saieva (C)

Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Florence, Italy.

Carlotta Becherini (C)

Department of Biomedical, Experimental and Clinical Sciences "M. Serio", University of Florence, Florence, Italy.

Viola Salvestrini (V)

Department of Biomedical, Experimental and Clinical Sciences "M. Serio", University of Florence, Florence, Italy.

Luca Visani (L)

Department of Biomedical, Experimental and Clinical Sciences "M. Serio", University of Florence, Florence, Italy.

Giulia Stocchi (G)

Department of Biomedical, Experimental and Clinical Sciences "M. Serio", University of Florence, Florence, Italy.

Chiara Bellini (C)

Department of Biomedical, Experimental and Clinical Sciences "M. Serio", University of Florence, Florence, Italy.

Victoria Lorenzetti (V)

Department of Biomedical, Experimental and Clinical Sciences "M. Serio", University of Florence, Florence, Italy.

Silvia Sordi (S)

Breast Surgery, Breast Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, University of Florence, L.go Brambilla 3, 50134, Florence, Italy.

Jacopo Nori (J)

Diagnostic Senology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.

Diego De Benedetto (D)

Diagnostic Senology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.

Isacco Desideri (I)

Department of Biomedical, Experimental and Clinical Sciences "M. Serio", University of Florence, Florence, Italy.
Radiotherapy Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.

Simonetta Bianchi (S)

Pathology Division, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.

Lorenzo Livi (L)

Department of Biomedical, Experimental and Clinical Sciences "M. Serio", University of Florence, Florence, Italy.
Radiotherapy Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.

Lorenzo Orzalesi (L)

Breast Surgery, Breast Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, University of Florence, L.go Brambilla 3, 50134, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH